Tag: HFrEF (heart failure with reduced ejection fraction)

1. Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF patients. 2. ...

1. In this randomized controlled trial, ferric carboxymaltose was not superior to placebo in improving death and hospitalization in patients ...

1. Patients assigned to hemodynamic monitoring reported improved quality of life than those receiving contemporary guideline-directed medical therapy. 2. The ...

1. SGLT-2 inhibitors reduced time to first hospitalization and cardiovascular death among patients with preserved, mildly reduced, and reduced ejection ...

1. In this randomized controlled trial, among 276 patients with chronic heart failure with reduced ejection fraction, omecamtiv mecarbil did ...

This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...

1. Dapagliflozin reduced the risk of worsening heart failure or cardiovascular death regardless of frailty status. 2. Dapagliflozin improved quality ...

1. There was no significant difference in the primary composite endpoint between the interatrial shunt and sham procedure groups. 2. ...

1. A prediction of the long-term effects of dapagliflozin from the short-term data in the Dapagliflozin and Prevention of Adverse-Outcomes ...

1. Hypertension, diabetes, smoking, atrial fibrillation, and previous myocardial infarction were associated with a higher risk of incident heart failure ...